Department of Psychiatry, Mood Disorders Centre, University of British Columbia, Vancouver, BC, Canada.
Bipolar Disord. 2010 Sep;12(6):616-26. doi: 10.1111/j.1399-5618.2010.00855.x.
Up to 75% of patients with bipolar I disorder (BD-I) are overweight or obese. Obesity is associated with an increased liability for mood episodes in patients with established BD-I, but data from early in the illness are lacking. Obesity in the general population is also consistently associated with functional impairment, but the relationship between weight gain and functional outcomes in BD-I has received little attention.
We measured rates of clinically significant weight gain (CSWG), defined as gaining ≥ 7% of baseline weight, over 12 months in 46 patients with BD-I who recently recovered from their first manic episode. We compared patients with and without CSWG for (i) the amount of time spent with mood symptoms, assessed using standard clinical rating scales and National Institute of Mental Health Life Charts, and (ii) functioning at 12 months, measured using the Multidimensional Scale of Independent Functioning (MSIF).
A total of 41% of patients (n = 19) experienced CSWG by 12 months. We did not detect an association between CSWG and the number of days with mood symptoms. Patients with CSWG had significantly poorer 12-month global functioning than those without CSWG [MSIF score = 2.26 (SD = 1.24) versus 1.74 (0.98); p = 0.011]. Functional impairment was independent of recent or current mood symptoms, which were entered as covariates in our analyses.
Weight gain may be an overlooked, but potentially modifiable, cause of functional impairment in BD-I. Clinicians should consider the possibility of weight gain when making the earliest treatment decisions in BD-I.
高达 75%的双相情感障碍 I 型(BD-I)患者超重或肥胖。肥胖与已确诊的 BD-I 患者情绪发作的易感性增加有关,但在疾病早期缺乏相关数据。普通人群中的肥胖也与功能障碍密切相关,但 BD-I 中体重增加与功能结果之间的关系尚未得到充分关注。
我们在最近从首次躁狂发作中恢复的 46 名 BD-I 患者中测量了 12 个月内临床显著体重增加(CSWG)的发生率,定义为体重比基线增加≥7%。我们比较了有和无 CSWG 的患者在以下方面的差异:(i)使用标准临床评分量表和国家心理健康研究所生活图表评估的情绪症状持续时间;(ii)在 12 个月时的功能,使用多维独立功能评估量表(MSIF)进行测量。
共有 41%的患者(n=19)在 12 个月时出现 CSWG。我们未发现 CSWG 与情绪症状天数之间存在关联。CSWG 患者的 12 个月总体功能显著差于无 CSWG 患者[MSIF 评分=2.26(SD=1.24)对 1.74(0.98);p=0.011]。功能障碍与近期或当前的情绪症状无关,这些症状在我们的分析中被作为协变量纳入。
体重增加可能是 BD-I 中被忽视但潜在可改变的功能障碍的原因。临床医生在 BD-I 中做出最早的治疗决策时,应考虑体重增加的可能性。